12 results
10-K
2021 FY
OLPX
Olaplex Holdings Inc
8 Mar 22
Annual report
2:59pm
product complaint and recall files and voluntarily report adverse events to the agency. The FDA monitors compliance of cosmetic products through market … independently
Table of Contents
decide to conduct a recall or market withdrawal of product or to make changes to its manufacturing processes or product
424B4
OLPX
Olaplex Holdings Inc
1 Oct 21
Prospectus supplement with pricing info
4:17pm
that can be included in our product, resulting in product reformulations, or the recall and discontinuation of certain products that cannot … maintain product complaint and recall files and voluntarily report adverse events to the agency.
We rely on third parties to manufacture our products
S-1/A
EX-1.1
835 yxsy9f65h
20 Sep 21
IPO registration (amended)
10:27am
S-1/A
9s05ir
20 Sep 21
IPO registration (amended)
10:27am
S-1
EX-10.5
ygrrfs8v526bbzs5r1ih
27 Aug 21
IPO registration
3:55pm
S-1
i4rmp kip8
27 Aug 21
IPO registration
3:55pm
DRS/A
5xsufcex2k 7in5
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
EX-10.5
rshf97jxbu586650
28 Jun 21
Draft registration statement
12:00am
DRS
3cm75dzd
28 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next